Embolic Stroke of Undetermined Source and Patent Foramen Ovale Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction

被引:28
|
作者
Strambo, Davide [1 ,2 ]
Sirimarco, Gaia [1 ,2 ]
Nannoni, Stefania [1 ,2 ]
Perlepe, Kalliopi [3 ]
Ntaios, George [3 ]
Vemmos, Kostantinos [4 ]
Michel, Patrik [1 ,2 ]
机构
[1] Lausanne Univ Hosp, Dept Clin Neurosci, Serv Neurol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne, Lausanne, Switzerland
[3] Univ Thessaly, Sch Hlth Sci, Dept Internal Med, Fac Med, Larisa, Greece
[4] Alexandra Hosp, Med Sch Athens, Dept Clin Therapeut, Athens, Greece
关键词
atrial fibrillation; Bayes theorem; embolic stroke; foramen ovale; patent; prevalence; CRYPTOGENIC STROKE; MEDICAL THERAPY; ISCHEMIC-STROKE; CLOSURE; REGISTRY;
D O I
10.1161/STROKEAHA.120.032453
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose: The Risk of Paradoxical Embolism (RoPE) score stratifies patients with stroke according to the probability of having a patent foramen ovale (PFO), which (through Bayes theorem and simple assumptions) can be used to estimate the probability that a PFO is pathogenic in a given subgroup of patients with specific features (ie, a given RoPE score value): a higher PFO prevalence corresponds to a higher probability that a PFO is pathogenic. Among alternative mechanisms in embolic stroke of undetermined source (ESUS), the actual stroke cause may be covert atrial fibrillation. We aimed to validate the RoPE score in a large ESUS population and investigate the rate of stroke recurrence and new incident atrial fibrillation during follow-up according to PFO status and RoPE score. Methods: We pooled data of consecutive patients with ESUS from 3 prospective stroke registries. We assessed RoPE score's calibration and discrimination for the presence of PFO (and consequently for the probability that it is pathogenic). Multivariate logistic regression analysis was performed to identify factors associated with PFO. Results: Among 455 patients with ESUS (median age 59 years), 184 (40%) had PFO. The RoPE score's area under the receiver operating characteristic curve was 0.75. In addition to RoPE score variables, absence of left ventricular hypertrophy, absence of atherosclerosis, and infratentorial lesions were independently associated with PFO. In patients with PFO and RoPE 7 to 10, PFO and RoPE 0 to 6, and without PFO, new incident atrial fibrillation rate was 3.1%, 20.5%, and 31.8%, respectively (log-rank test=6.28, P=0.04). Stroke recurrences in patients with likely pathogenic PFO were not statistically different from other patients. Conclusions: This multicenter study validates the RoPE score to predict the presence/absence of PFO in patients with ESUS, which strongly suggests that RoPE score is helpful in identifying patients with ESUS with pathogenic versus incidental PFOs. Left ventricular hypertrophy, atherosclerosis, and infratentorial stroke may further improve the score. Low RoPE scores were associated with more incidental atrial fibrillation during 10-year follow-up.
引用
收藏
页码:1643 / 1652
页数:10
相关论文
共 50 条
  • [41] PARADOXICAL EMBOLISM RISK INCREASES WITH ATYPICAL RIGHT ATRIAL BLOOD FLOW IN THE PRESENCE OF A PATENT FORAMEN OVALE
    Stoll, Victoria
    Hess, Aaron
    Rider, Oliver
    Harvey, Hayley
    Pitcher, Alex
    Loudon, Margaret
    Bissell, Malenka
    Neubauer, Stefan
    Ormerod, Oliver
    Myerson, Saul
    HEART, 2016, 102 : A97 - A98
  • [42] Percutaneous Closure of Patent Foramen Ovale and the Risk of Atrial Fibrillation
    Bhindi, Ravinay
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 75 (02) : 301 - 301
  • [43] Cryptogenic Stroke and Embolic Stroke of Undetermined Source: Risk Factors and Approaches for Detection of Atrial Fibrillation
    Rakhimova, Idaliya
    Semenova, Yuliya
    Khaibullin, Talgat
    Kuanysheva, Anargul
    Kovalchuk, Vitalii
    Abdrakhmanov, Ayan
    CURRENT CARDIOLOGY REVIEWS, 2022, 18 (04) : 55 - 68
  • [44] Patent Foramen Ovale and Other Cardiopathies as Causes of Embolic Stroke With Unknown Source
    Kim, Jong S.
    JOURNAL OF STROKE, 2024, 26 (03) : 349 - 359
  • [45] INCIDENCE OF ATRIAL FIBRILLATION IN PATIENTS WITH CRYPTOGENIC STROKE AND PATENT FORAMEN OVALE
    Cesaretti, S.
    Ciuca, C.
    Mariucci, M.
    Assenza, G. Egidy
    Balducci, A.
    Bonetti, S.
    Donti, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G173 - G173
  • [46] Detection of paroxysmal atrial fibrillation and patent foramen ovale in cryptogenic stroke
    Stoellberger, C.
    Finsterer, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (02) : 160 - 161
  • [47] Patent Foramen Ovale May Decrease the Risk of Left Atrial Thrombosis in Stroke Patients With Atrial Fibrillation
    Baik, Minyoul
    Shim, Chi Young
    Gwak, Seo-Yeon
    Kim, Young Dae
    Nam, Hyo Suk
    Jeon, Soyoung
    Lee, Hye Sun
    Heo, Ji Hoe
    JOURNAL OF STROKE, 2023, 25 (03) : 417 - +
  • [48] Validation of the AF-ESUS score to identify patients with embolic stroke of undetermined source and low risk of device-detected atrial fibrillation
    Kitsiou, Alkisti
    Sagris, Dimitrios
    Schaebitz, Wolf-Rudiger
    Ntaios, George
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 135 - 136
  • [49] The relationship between the size of patent foramen ovale and the risk of paradoxical cerebral embolism
    Kouchi, M.
    Mizuma, A.
    Netsu, S.
    Kijima, C.
    Takizawa, S.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 244 - 244
  • [50] Interventional closure of patent foramen ovale and atrial septal defects after paradoxical embolic events
    Beitzke, A
    Schuchlenz, H
    Beitzke, M
    Gamillscheg, A
    Stein, HI
    Zartner, P
    ZEITSCHRIFT FUR KARDIOLOGIE, 2002, 91 (09): : 693 - 700